Mapping oncogenic protein interactions for precision medicine.

Authors:
Sharifi Tabar M; Francis H; Yeo D; Bailey CG; Rasko JEJ.

Journal:
Int J Cancer

Publication Year: 2022

DOI:
10.1002/ijc.33954

PMCID:
PMC9306658

PMID:
35113472

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Int J Cancer

Abbreviation: Int J Cancer

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neoplasms

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Chronic acidosis rewires cancer cell metabolism through PPARα signaling.
Rolver MG; Holland LKK; Ponniah M and 11 more (2023) - Transparency Score: 4/6
A defect of amphiregulin release predicted longer survival independently of YAP expression in patie…
Maille E; Levallet J; Dubois F and 17 more (2022) - Transparency Score: 3/6
Agricultural activities and risk of central nervous system tumors among French farm managers: Resul…
Petit P; Gandon G; Chabardès S and 1 more (2022) - Transparency Score: 3/6
A hybrid design for dose-finding oncology clinical trials.
Liao JJZ; Zhou F; Zhou H and 3 more (2022) - Transparency Score: 3/6
A nationwide longitudinal study on risk factors for progression of anal intraepithelial neoplasia g…
Faber MT; Frederiksen K; Palefsky JM and 1 more (2022) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST The authors declare no potential conflict of interests."

Evidence found in paper:

"Funding information Cancer Council NSW, Grant/Award Numbers: RG14‐05, RG14‐09, RG20‐07, RG20‐12; Cure the Future Foundation; Li Ka Shing Foundation; National Health and Medical Research Council, Grant/Award Numbers: 1128748, 1177305; Tour de Cure"

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025